I

ITF Therapeutics

Develops and commercializes rare-disease therapies

Director, Patient Services - Neuromuscular Disorders

Business OperationsConfirmed live in the last 24 hours
Full-timeRemote in USA$230k - $250k

About the Job

Requirements

  • A bachelor's degree is required; an advanced degree is preferred.
  • A minimum of 8–10 years of experience in the pharmaceutical, biotechnology, or life sciences industry is required.
  • Deep, practical expertise across specialty drug distribution, specialty pharmacy operations, and third-party patient service Hub frameworks is required.
  • At least 3–5 years of demonstrated success managing high-touch, lower-volume patient support models within the rare disease or orphan drug landscape is required.
  • A proven track record directly managing an external, third-party vendor relationship is required.
  • A robust, foundational understanding of HIPAA data privacy regulations and OIG guidelines governing patient support services and interaction with patient communities is required.

Responsibilities

  • Own the relationship and ultimate operational accountability for the company's patient support services and specialty pharmacy fulfillment.
  • Lead strategic design, business rules optimization, and daily operational execution of the patient access program, ensuring a high-touch patient, caregiver, and provider journey.
  • Manage a specialized in-home lab monitoring program.
  • Serve as the primary relationship manager and strategic point of contact for the exclusive combined Hub/Specialty Pharmacy partner.
  • Manage day-to-day operations, ensure vendor accountability, and optimize time-to-first-fill, overall conversion, and persistency metrics.
  • Maintain and update hub business rules, communication workflows, and standard operating procedures.
  • Refine the patient access program framework to eliminate commercial or government access barriers and minimize pipeline drop-offs.
  • Direct the third-party partner responsible for the specialized in-home lab monitoring program.
  • Ensure seamless operations, data aggregation, and compliant reporting flows back to prescribing healthcare providers and the company.
  • Maintain and enhance data exchange and analytics pipelines with the Hub/Specialty Pharmacy and ancillary vendors.
  • Synthesize patient funnel metrics, daily data feeds, operational key performance indicators, and adherence trends into actionable insights for leadership.
  • Partner with field reimbursement managers and national accounts teams to provide personalized issue resolution, address complex appeals, and resolve localized access challenges.
  • Maintain alignment with Marketing, Sales, Patient Advocacy, Medical Affairs, and Legal.
  • Oversee compliance, eligibility, and execution of commercial co-pay assistance, QuickStart/bridge programs, and Patient Assistance Programs.

Desired Qualifications

  • Direct experience managing an exclusive or all-in combined Hub/Specialty Pharmacy partner model is highly preferred.
  • Prior experience overseeing clinical nursing networks, field health educators, or in-home diagnostic/lab monitoring programs is highly advantageous.

About the Company

ITF Therapeutics

Develops and commercializes rare-disease therapies

ITF Therapeutics is a division of Italfarmaco S.p.A. focused on developing and commercializing treatments for rare diseases in the U.S., especially Duchenne Muscular Dystrophy (DMD). The company works on early-stage research and clinical development, partnering with patient advocacy groups and clinical leaders to align programs with patient needs. Its lead program is DUVYZAT (givinostat), a histone deacetylase (HDAC) inhibitor aimed at DMD. Revenue comes from bringing these specialized therapies to market. Compared with competitors, ITF Therapeutics emphasizes collaboration with patient groups and clinicians, a pipeline-focused early-development approach, and a specialty in HDAC inhibitors for rare diseases. The company’s goal is to deliver effective treatments for rare-disease patients by advancing promising therapies through development and into commercialization.

Company size
1-10
Company stage
Not listed
Total funding
Not listed
Headquarters
Concord, NH
Founded
2024

Recently Posted Jobs

Explore more opportunities at ITF Therapeutics

See more jobs